4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide

C50H52BBrN8O4 — CID 157306657

IUPAC4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide
SMILESBrc1cncc2ccccc12.CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1.CN(C)C(=O)Cn1cc(-c2ccc(B3OC(C)(C)C(C)(C)O3)cc2)cn1
InChIInChI=1S/C22H20N4O.C19H26BN3O3.C9H6BrN/c1-25(2)22(27)15-26-14-19(12-24-26)16-7-9-17(10-8-16)21-13-23-11-18-5-3-4-6-20(18)21;1-18(2)19(3,4)26-20(25-18)16-9-7-14(8-10-16)15-11-21-23(12-15)13-17(24)22(5)6;10-9-6-11-5-7-3-1-2-4-8(7)9/h3-14H,15H2,1-2H3;7-12H,13H2,1-6H3;1-6H
InChIKeyBCOAZDRWEYEBQH-UHFFFAOYSA-N
MW919.73 g/mol
LogP8.79
Rot. Bonds8

About 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide

4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide (PubChem CID 157306657) has the molecular formula C50H52BBrN8O4 and a molecular weight of 919.73 g/mol. Its IUPAC name is 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide.

Molecular Properties

Compound Name4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide
PubChem CID157306657
Molecular FormulaC50H52BBrN8O4
Molecular Weight919.73 g/mol
Exact Mass918.34
IUPAC Name4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide
SMILESBrc1cncc2ccccc12.CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1.CN(C)C(=O)Cn1cc(-c2ccc(B3OC(C)(C)C(C)(C)O3)cc2)cn1
InChIInChI=1S/C22H20N4O.C19H26BN3O3.C9H6BrN/c1-25(2)22(27)15-26-14-19(12-24-26)16-7-9-17(10-8-16)21-13-23-11-18-5-3-4-6-20(18)21;1-18(2)19(3,4)26-20(25-18)16-9-7-14(8-10-16)15-11-21-23(12-15)13-17(24)22(5)6;10-9-6-11-5-7-3-1-2-4-8(7)9/h3-14H,15H2,1-2H3;7-12H,13H2,1-6H3;1-6H
InChIKeyBCOAZDRWEYEBQH-UHFFFAOYSA-N
XLogP8.79
TPSA120.50 Ų
H-Bond Donors
H-Bond Acceptors10
Rotatable Bonds8
Heavy Atoms64
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500919.73
LogP ≤ 58.79
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide?
The IUPAC name of 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide (CID 157306657) is 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide.
What is the SMILES notation for 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide?
The canonical SMILES for 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide is Brc1cncc2ccccc12.CN(C)C(=O)Cn1cc(-c2ccc(-c3cncc4ccccc34)cc2)cn1.CN(C)C(=O)Cn1cc(-c2ccc(B3OC(C)(C)C(C)(C)O3)cc2)cn1.
What is the InChIKey of 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide?
The InChIKey is BCOAZDRWEYEBQH-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H20N4O.C19H26BN3O3.C9H6BrN/c1-25(2)22(27)15-26-14-19(12-24-26)16-7-9-17(10-8-16)21-13-23-11-18-5-3-4-6-20(18)21;1-18(2)19(3,4)26-20(25-18)16-9-7-14(8-10-16)15-11-21-23(12-15)13-17(24)22(5)6;10-9-6-11-5-7-3-1-2-4-8(7)9/h3-14H,15H2,1-2H3;7-12H,13H2,1-6H3;1-6H.
What are the key properties of 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide?
4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide has a molecular weight of 919.73 g/mol, XLogP of 8.79, 8 rotatable bonds, 0 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 4-bromoisoquinoline;N,N-dimethyl-2-[4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrazol-1-yl]acetamide;2-[4-(4-isoquinolin-4-ylphenyl)pyrazol-1-yl]-N,N-dimethylacetamide is sourced from PubChem (CID 157306657), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).